Zinc gluconate for treating cold symptoms needs more research -- JAMA study.
This article was originally published in The Tan Sheet
Executive Summary
ZINC SUPPLEMENTATION FOR COMMON COLD REQUIRES ADDITIONAL RESEARCH following the negative results of a 247-patient pediatric trial, Michael Macknin, MD, Cleveland Clinic Foundation, et al., report in the June 24 Journal of the American Medical Association. "Additional studies in all age groups with different dosages and formulations of zinc lozenges and with virologic testing are needed to define what role, if any, zinc has in the treatment of common cold symptoms," the researchers say. The study found that zinc lozenges did not provide improved relief of cold symptoms compared to placebo in children and adolescents in grades 1-12.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning